Imaging
Hitachi's SceptreC provides cardiac PET alternative at Society of Nuclear Medicine meeting
Published in Medical Devices and Surgical Technology Week, July 2nd, 2006
Specifically configured for cardiac PET, SceptreC allows the utilization of both Rubidium-82 for myocardial perfusion and 18-FDG for myocardial viability procedures.
"Whole-body PET/CT [computed tomography] offers significant throughput advantages for oncology," stated Raymond Wtulich, PET & PET/CT product manager for HMSA. "However, in cardiac imaging only one bed position is required for a stress or rest acquisition making dedicated PET a comparable...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Cardiovascular Disease
Transulnar artery approach for coronary interventions is safe and effective - Heart Transplantation
Artificial heart malfunction may be detected with an automatic diagnosis system - Molecular Diagnostics
RAPD technique genotypes coagulase-negative staphylococci strains within 4 hours - Surgical Technology
Coapsys mitral annuloplasty improves left ventricular shape - Surgical Technology
Gamma knife radiosurgery reduces morbidity and mortality of benign cranial base tumor surgery - Allergy & Immunology
Neogen adds simple strip test for total milk allergen - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
